ChiCTR2100049126
结束
/
/
/
2021-07-21
/
/
dry beriberi
Efficacy of Thiamine in Patients with Clinically Suspected Dry Beriberi: An Open Labeled Hospital Based Study in Bangladesh
Efficacy of Thiamine in Patients with Clinically Suspected Dry Beriberi: An Open Labeled Hospital Based Study in Bangladesh
4203
General objective: To evaluate the efficacy of Thiamine in patients with suspected / possible dry beriberi Specific objectives: 1. To describe the socio-demographic profile of patients; 2. To categorize the patients according to their presenting symptoms and signs; 3. To assess and compare pre and post treatment neurological features.
单臂
回顾性研究
N/A
N/A
self funding
/
55
/
2018-07-01
2018-06-30
/
1. Any person admitted to CMCH as a Suspected/Possible dry-beriberi. Risk factors + at least 2 of the following signs: Risk factors include Imbalanced diet (diet poor in thiamine/rich in carbohydrate or anti-thiamine factors), malnutrition, alcoholism, GIT surgery, chronic diarrhoea, chronic vomiting, pregnancy or history of recent delivery, chronic. diuretics use, renal dialysis, total parenteral nutrition. 1) Muscle weakness of upper and or lower limb (less than grade 5 power in MRC scale); 2) Positive sensory symptoms (burning, tingling or pain); 3) Objective sensory deficit (pain, touch, position, vibration sense); 4) Absent or reduced deep tendon reflexes; 5) Positive squat test (unable to rise after squatting without help);6) Leg swelling; 2. Aged 18 years and above.；
请登录查看1. Patients with isolated cardiac/wet beriberi; 2. Patient with known causes of peripheral neuropathy such as Diabetic, hereditary, Demyelinating (GBS, CIDP), metabolic (hepatic/renal impairment), drugs (e.g. INH, Ethambutol, Phenytoin, Metronidazole, Dapsone etc.) Toxin (As ,OPC, Pb ,Hg except alcohol) etc.; 3. Patients refuse to participate.；
请登录查看Dr. Nayema Masrura
4203
肝脏时间2026-06-23
丁香园 Insight 数据库2026-06-23
医药观澜2026-06-23
药研网2026-06-23
生物技术小编2026-06-23
一度医药2026-06-23
干细胞与外泌体2026-06-23
药渡2026-06-23
药明康德2026-06-23
医药笔记2026-06-23
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
